Država: Irska
Jezik: engleski
Izvor: HPRA (Health Products Regulatory Authority)
Clotrimazole
Bayer Limited
G01AF; G01AF02
Clotrimazole
500 milligram(s)
Vaginal capsule, soft
Product not subject to medical prescription
Imidazole derivatives; clotrimazole
Not marketed
2014-12-12
BCH22024 PACKAGE LEAFLET: INFORMATION FOR THE USER CANESTEN ® 500MG SOFT VAGINAL CAPSULE Clotrimazole READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always use this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse have told you. • Keep this leaflet. You may need to read it again. • Ask your pharmacist if you need more information or advice. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. • You must talk to a doctor if you do not feel better or if you feel worse after 7 days. WHAT IS IN THIS LEAFLET 1. What Canesten Soft Vaginal Capsule is and what it is used for 2. What you need to know before you use Canesten Soft Vaginal Capsule 3. How to use Canesten Soft Vaginal Capsule 4. Possible side effects 5. How to store Canesten Soft Vaginal Capsule 6. Contents of the pack and other information 1. WHAT CANESTEN ® SOFT VAGINAL CAPSULE IS AND WHAT IT IS USED FOR Canesten Soft Vaginal Capsule is a single application for the treatment of vaginal thrush. It is inserted into the vagina for treatment at the site of infection. ONLY USE THIS PRODUCT IF YOU HAVE BEEN PREVIOUSLY DIAGNOSED BY YOUR DOCTOR AS HAVING VAGINAL THRUSH. The active substance in Canesten Soft Vaginal Capsule is clotrimazole. Clotrimazole belongs to a group of medicines called azoles and is an antifungal agent which fights the cause of infections such as vaginal thrush. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE CANESTEN ® SOFT VAGINAL CAPSULE DO NOT USE CANESTEN ® SOFT VAGINAL CAPSULE: • If you are allergic to clotrimazole or any of the other ingredients of Canesten Soft Vaginal Capsule ( _listed in Section 6_ ). WARNINGS AND PRECAUTIONS TALK TO YOUR DOCTOR OR PHARMACIST BEFORE USING CANESTEN ® SOFT VAGINAL CAPSULE IF: • You are unsure whether you have thrush or this is the first time you have had these symptoms. • You have had mo Pročitajte cijeli dokument
Health Products Regulatory Authority 05 December 2022 CRN00D655 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Canesten 500mg Soft Vaginal Capsule 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each soft vaginal capsule contains 500mg Clotrimazole. Excipients with known effect: Soya oil For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Vaginal capsule, soft Yellow teardrop-shaped soft capsule 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Canesten Soft Vaginal Capsules are recommended for the treatment of candidal vaginitis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Adults: One 500mg soft vaginal capsule should be inserted at night before going to bed. A second treatment may be carried out if necessary. Patients should be advised to consult their physician if the symptoms have not been relieved within one week of using Canesten Soft Vaginal Capsule. Canesten Soft Vaginal Capsules can be used again if the candidal infection returns after 7 days. However, if the candidal infection recurs more than twice within six months, patients should be advised to consult their physician. _Paediatric population_ Not for use in children under 16. Method of administration The soft vaginal capsule should be inserted as high as possible into the vagina, using the applicator provided. This is best achieved when lying back with legs bent up. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Medical advice should be sought if this is the first time the patient has experienced symptoms of candidal vaginitis. Before using Canesten Soft Vaginal Capsule, medical advice must be sought if any of the following are applicable: Health Products Regulatory Authority 05 December 2022 CRN00D655 Page 2 of 6 - more than two infections of candidal vaginitis in the last 6 months. - previous history of sexually transmitted disease or exposure to partner with sexually transmitted disea Pročitajte cijeli dokument